402 related articles for article (PubMed ID: 11721421)
21. [Rapid onset of hemolytic anemia after allogeneic bone marrow transplantation from an unrelated ABO major mismatched donor].
Watanabe H; Asai O; Tada N; Yano S; Katoh A; Katori M; Kobayashi T; Kuraishi Y; Hoshi Y; Itoh K; Aizawa S
Rinsho Ketsueki; 1997 Jan; 38(1):14-20. PubMed ID: 9028156
[TBL] [Abstract][Full Text] [Related]
22. Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemia.
Benjamin RJ; Connors JM; McGurk S; Churchill WH; Antin JH
Biol Blood Marrow Transplant; 1998; 4(3):151-6. PubMed ID: 9923413
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin.
Santamaría A; Sureda A; Martino R; Domingo-Albós A; Muñiz-Díaz E; Brunet S
Bone Marrow Transplant; 1997 Dec; 20(12):1105-7. PubMed ID: 9466287
[TBL] [Abstract][Full Text] [Related]
24. Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation.
Kim JG; Sohn SK; Kim DH; Baek JH; Lee KB; Min WS; Kim CC; Lee MH; Lee JJ; Chung IJ; Kim HJ; Lee JW
Bone Marrow Transplant; 2005 Mar; 35(5):489-95. PubMed ID: 15654350
[TBL] [Abstract][Full Text] [Related]
25. Bone marrow transplantation with major ABO incompatibility. Experience of the Bone Marrow Transplantation Unit--Francisco Gentil Portuguese Institute of Oncology, Lisbon Centre.
Coelho R; Cunha I; Nolasco I; Machado A; Abecassis M
Acta Med Port; 1994 Dec; 7 Suppl 1():S21-4. PubMed ID: 7653275
[TBL] [Abstract][Full Text] [Related]
26. Impact of ABO incompatibility on engraftment and transfusion requirement after unrelated cord blood transplantation: a single institute experience in Japan.
Tomonari A; Takahashi S; Ooi J; Tsukada N; Konuma T; Kobayashi T; Sato A; Iseki T; Yamaguchi T; Tojo A; Asano S
Bone Marrow Transplant; 2007 Sep; 40(6):523-8. PubMed ID: 17646845
[TBL] [Abstract][Full Text] [Related]
27. [Pure red cell aplasia after allogeneic transplantation of ABO incompatible hematopoietic stem cells].
Bullorsky E; Shanley C; Stemmelin G; Ceresetto J; Rabinovich O
Medicina (B Aires); 2002; 62(6):575-7. PubMed ID: 12532694
[TBL] [Abstract][Full Text] [Related]
28. Delayed erythropoiesis after major ABO-incompatible bone marrow transplantation: report of a case.
Tang JL; Lin MT; Wang CH; Lin DT; Chen YC
J Formos Med Assoc; 1990 Oct; 89(10):892-5. PubMed ID: 1981778
[TBL] [Abstract][Full Text] [Related]
29. CD34+-enriched donor lymphocyte infusions in a case of pure red cell aplasia and late graft failure after major ABO-incompatible bone marrow transplantation.
Selleri C; Raiola A; De Rosa G; Luciano L; Pezzullo L; Picardi M; Rotoli B
Bone Marrow Transplant; 1998 Sep; 22(6):605-7. PubMed ID: 9758354
[TBL] [Abstract][Full Text] [Related]
30. Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation.
Ozkurt ZN; Yegin ZA; Yenicesu I; Aki SZ; Yagci M; Sucak GT
Transplant Proc; 2009 Nov; 41(9):3851-8. PubMed ID: 19917400
[TBL] [Abstract][Full Text] [Related]
31. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
[TBL] [Abstract][Full Text] [Related]
32. ABO-incompatible bone marrow transplantation: prevention of hemolysis by alkaline hydration with mannitol diuresis in conjunction with red cell reduced buffy coat bone marrow.
Slavc I; Urban C; Schwinger W; Hauer C; Vadon M
Wien Klin Wochenschr; 1992; 104(4):93-6. PubMed ID: 1570714
[TBL] [Abstract][Full Text] [Related]
33. Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?
Mehta J; Powles R; Sirohi B; Treleaven J; Kulkarni S; Saso R; Tait D; Singhal S
Bone Marrow Transplant; 2002 May; 29(10):853-9. PubMed ID: 12058235
[TBL] [Abstract][Full Text] [Related]
34. Is the ABO incompatibility a risk factor in bone marrow transplantation?
Rozman P; Kosir A; Bohinjec M
Transpl Immunol; 2005 Aug; 14(3-4):159-69. PubMed ID: 15982558
[TBL] [Abstract][Full Text] [Related]
35. Adult ABO-incompatible liver transplantation, using A and B donors.
Skogsberg U; Breimer ME; Friman S; Mjörnstedt L; Mölne J; Olausson M; Rydberg L; Svalander CT; Bäckman L
Xenotransplantation; 2006 Mar; 13(2):154-9. PubMed ID: 16623811
[TBL] [Abstract][Full Text] [Related]
36. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
[TBL] [Abstract][Full Text] [Related]
37. After major ABO-mismatched allogeneic hematopoietic progenitor cell transplantation, erythroid engraftment occurs later in patients with donor blood group A than donor blood group B.
Schetelig J; Breitschaft A; Kröger N; Zabelina T; Ebell W; Bornhäuser M; Haack A; Ehninger G; Salama A; Siegert W;
Transfusion; 2005 May; 45(5):779-87. PubMed ID: 15847669
[TBL] [Abstract][Full Text] [Related]
38. [Administration of haptoglobin in ABO incompatible bone marrow transplantation].
Ito M; Imoto S; Nakagawa T; Kai S; Hara H
Rinsho Ketsueki; 1990 Oct; 31(10):1716-20. PubMed ID: 2255063
[TBL] [Abstract][Full Text] [Related]
39. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
[TBL] [Abstract][Full Text] [Related]
40. Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant.
Labar B; Bogdanić V; Nemet D; Kovacević-Metelko J; Mrsić M; Pavletić Z; Zupancić-Salek S; Radman I; Aurer I
Bone Marrow Transplant; 1992 Nov; 10(5):471-2. PubMed ID: 1464014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
